查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1487587

眼部藥物傳遞技術市場（技術：局部、眼部插入、離子電滲透療法、眼內植入、原位凝膠和淚點塞等）- 全球產業分析、規模、佔有率、成長、趨勢和預測， 2024-2034 年

Ocular Drug Delivery Technology Market (Technology: Topical, Ocular Insert, Iontophoresis, Intraocular Implant, In Situ Gel & Punctal Plug, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
出版日期: | 出版商: Transparency Market Research | 英文 214 Pages | 商品交期: 2-10個工作天內

價格

眼部給藥技術市場 - 報告範圍

TMR 關於全球眼部藥物輸送技術市場的報告研究了過去以及當前的成長趨勢和機會，以獲得 2024 年至 2034 年預測期內市場指標的寶貴見解。 2034 年交付技術市場，以2024 年為基準年，2034 年為預測年。報告中也提供了2024年至2034年全球眼部給藥技術市場的年複合成長率（CAGR%）。

該報告是經過廣泛研究後編寫的。初級研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了採訪。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解眼部藥物傳輸技術市場。

市場概況
2023年市場價值 163 億美元
2034 年市場價值 302 億美元
複合年成長率 5.7%

該報告深入探討了全球眼部給藥技術市場的競爭格局。全球眼部藥物輸送技術市場的主要參與者已經確定，並對每個參與者的各種屬性進行了分析。公司概況、財務狀況、最新發展和 SWOT 是本報告中介紹的全球眼部藥物輸送技術市場參與者的屬性。

目錄

第1章：前言

第 2 章：假設與研究方法

第 3 章：執行摘要：全球市場

第 4 章：市場概覽

  • 介紹
  • 概述
  • 市場動態
  • 2020-2034年全球市場分析與預測

第 5 章：關鍵見解

  • 管道分析
  • 主要產品/品牌分析
  • 主要併購
  • COVID-19 大流行對該行業的影響

第 6 章：全球市場分析與預測：依技術分類

  • 簡介和定義
  • 主要發現/進展
  • 市場價值預測：依技術分類，2020-2034
    • 專題
    • 眼插入物
      • 易蝕的
      • 不易腐蝕
    • 離子電滲透療法
    • 眼內植入物
      • 可生物分解
      • 非生物分解
    • 原位凝膠和淚點塞
    • 其他
  • 市場吸引力：依技術分類

第 7 章：全球市場分析與預測：依配方類型

  • 簡介和定義
  • 主要發現/進展
  • 市場價值預測：依配方類型，2020-2034年
    • 解決方案
    • 暫停
    • 乳液
    • 脂質體和奈米顆粒
    • 軟膏
  • 市場吸引力：按配方類型

第 8 章：全球市場分析與預測：按疾病類型

  • 簡介和定義
  • 主要發現/進展
  • 市場價值預測：依疾病類型，2020-2034
    • 青光眼
    • 黃斑部病變
    • 糖尿病性視網膜病變
    • 白內障
    • 糖尿病黃斑水腫
    • 乾眼症
    • 其他
  • 市場吸引力：按疾病類型

第 9 章：全球市場分析與預測：按最終用戶

  • 簡介和定義
  • 主要發現/進展
  • 市場價值預測：按最終用戶，2020-2034
    • 醫院
    • 門診手術中心
    • 眼科診所
    • 家庭護理設置
  • 市場吸引力：按最終用戶分類

第 10 章：全球市場分析與預測：按地區

  • 主要發現
  • 市場價值預測：按地區，2020-2034
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力：按地區

第 11 章：北美市場分析與預測

第 12 章：歐洲市場分析與預測

第 13 章：亞太市場分析與預測

第 14 章：拉丁美洲市場分析與預測

第 15 章：中東和非洲市場分析與預測

第16章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 市佔率分析：依公司分類（2023）
  • 公司簡介
    • Ocular Therapeutix, Inc.
    • Alimera Sciences Inc.
    • Allergan (an AbbVie company)
    • Bausch Health Companies Inc.
    • EyeGate Pharmaceuticals, Inc.
    • Envisia Therapeutics Inc.
    • Clearside Biomedical, Inc.
    • Graybug Vision, Inc.
    • Santen Pharmaceutical Co., Ltd.
    • Taiwan Liposome Company, Ltd.
Product Code: TMRGL2869

Ocular Drug Delivery Technology Market - Scope of Report

TMR's report on the global ocular drug delivery technology market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global ocular drug delivery technology market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global ocular drug delivery technology market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the ocular drug delivery technology market.

Market Snapshot
Market Value in 2023US$ 16.3 Bn
Market Value in 2034US$ 30.2 Bn
CAGR5.7%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global ocular drug delivery technology market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global ocular drug delivery technology market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global ocular drug delivery technology market.

The report delves into the competitive landscape of the global ocular drug delivery technology market. Key players operating in the global ocular drug delivery technology market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global ocular drug delivery technology market profiled in this report.

Key Questions Answered in Global ocular drug delivery technology Market Report:

  • What is the sales/revenue generated by ocular drug delivery technology across all regions during the forecast period?
  • What are the opportunities in the global ocular drug delivery technology market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Ocular Drug Delivery Technology Market - Research Objectives and Research Approach

The comprehensive report on the global ocular drug delivery technology market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global ocular drug delivery technology market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global ocular drug delivery technology market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Ocular Drug Delivery Technology Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Ocular Drug Delivery Technology Market Analysis and Forecast, 2020-2034

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Ocular Drug Delivery Technology Market Analysis and Forecast, by Technology

  • 6.1. Introduction and Definitions
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Technology, 2020-2034
    • 6.3.1. Topical
    • 6.3.2. Ocular Insert
      • 6.3.2.1. Erodible
      • 6.3.2.2. Non-erodible
    • 6.3.3. Iontophoresis
    • 6.3.4. Intraocular Implant
      • 6.3.4.1. Biodegradable
      • 6.3.4.2. Non-biodegradable
    • 6.3.5. In Situ Gel & Punctal Plug
    • 6.3.6. Others
  • 6.4. Market Attractiveness, by Technology

7. Global Ocular Drug Delivery Technology Market Analysis and Forecast, by Formulation Type

  • 7.1. Introduction and Definitions
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Formulation Type, 2020-2034
    • 7.3.1. Solution
    • 7.3.2. Suspension
    • 7.3.3. Emulsion
    • 7.3.4. Liposome & Nanoparticle
    • 7.3.5. Ointment
  • 7.4. Market Attractiveness, by Formulation Type

8. Global Ocular Drug Delivery Technology Market Analysis and Forecast, by Disease Type

  • 8.1. Introduction and Definitions
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Disease Type, 2020-2034
    • 8.3.1. Glaucoma
    • 8.3.2. Macular Degeneration
    • 8.3.3. Diabetic Retinopathy
    • 8.3.4. Cataract
    • 8.3.5. Diabetic Macular Edema
    • 8.3.6. Dry Eye Syndrome
    • 8.3.7. Others
  • 8.4. Market Attractiveness, by Disease Type

9. Global Ocular Drug Delivery Technology Market Analysis and Forecast, by End-user

  • 9.1. Introduction and Definitions
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by End-user, 2020-2034
    • 9.3.1. Hospitals
    • 9.3.2. Ambulatory Surgical Centers
    • 9.3.3. Ophthalmic Clinics
    • 9.3.4. Homecare Settings
  • 9.4. Market Attractiveness, by End-user

10. Global Ocular Drug Delivery Technology Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2020-2034
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness, by Region

11. North America Ocular Drug Delivery Technology Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Technology, 2020-2034
    • 11.2.1. Topical
    • 11.2.2. Ocular Insert
      • 11.2.2.1. Erodible
      • 11.2.2.2. Non-erodible
    • 11.2.3. Iontophoresis
    • 11.2.4. Intraocular Implant
      • 11.2.4.1. Biodegradable
      • 11.2.4.2. Non-biodegradable
    • 11.2.5. In Situ Gel & Punctal Plug
    • 11.2.6. Others
  • 11.3. Market Attractiveness, by Technology
  • 11.4. Market Value Forecast, by Formulation Type, 2020-2034
    • 11.4.1. Solution
    • 11.4.2. Suspension
    • 11.4.3. Emulsion
    • 11.4.4. Liposome & Nanoparticle
    • 11.4.5. Ointment
  • 11.5. Market Attractiveness, by Formulation Type
  • 11.6. Market Value Forecast, by Disease Type, 2020-2034
    • 11.6.1. Glaucoma
    • 11.6.2. Macular Degeneration
    • 11.6.3. Diabetic Retinopathy
    • 11.6.4. Cataract
    • 11.6.5. Diabetic Macular Edema
    • 11.6.6. Dry Eye Syndrome
    • 11.6.7. Others
  • 11.7. Market Attractiveness, by Disease Type
  • 11.8. Market Value Forecast, by End-user, 2020-2034
    • 11.8.1. Hospitals
    • 11.8.2. Ambulatory Surgical Centers
    • 11.8.3. Ophthalmic Clinics
    • 11.8.4. Homecare Settings
  • 11.9. Market Attractiveness, by End-user
  • 11.10. Market Value Forecast, by Country, 2020-2034
    • 11.10.1. U.S.
    • 11.10.2. Canada
  • 11.11. Market Attractiveness Analysis
    • 11.11.1. By Technology
    • 11.11.2. By Formulation Type
    • 11.11.3. By Disease Type
    • 11.11.4. By End-user
    • 11.11.5. By Country

12. Europe Ocular Drug Delivery Technology Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Technology, 2020-2034
    • 12.2.1. Topical
    • 12.2.2. Ocular Insert
      • 12.2.2.1. Erodible
      • 12.2.2.2. Non-erodible
    • 12.2.3. Iontophoresis
    • 12.2.4. Intraocular Implant
      • 12.2.4.1. Biodegradable
      • 12.2.4.2. Non-biodegradable
    • 12.2.5. In Situ Gel & Punctal Plug
    • 12.2.6. Others
  • 12.3. Market Attractiveness, by Technology
  • 12.4. Market Value Forecast, by Formulation Type, 2020-2034
    • 12.4.1. Solution
    • 12.4.2. Suspension
    • 12.4.3. Emulsion
    • 12.4.4. Liposome & Nanoparticle
    • 12.4.5. Ointment
  • 12.5. Market Attractiveness, by Formulation Type
  • 12.6. Market Value Forecast, by Disease Type, 2020-2034
    • 12.6.1. Glaucoma
    • 12.6.2. Macular Degeneration
    • 12.6.3. Diabetic Retinopathy
    • 12.6.4. Cataract
    • 12.6.5. Diabetic Macular Edema
    • 12.6.6. Dry Eye Syndrome
    • 12.6.7. Others
  • 12.7. Market Attractiveness, by Disease Type
  • 12.8. Market Value Forecast, by End-user, 2020-2034
    • 12.8.1. Hospitals
    • 12.8.2. Ambulatory Surgical Centers
    • 12.8.3. Ophthalmic Clinics
    • 12.8.4. Homecare Settings
  • 12.9. Market Attractiveness, by End-user
  • 12.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 12.10.1. Germany
    • 12.10.2. U.K.
    • 12.10.3. France
    • 12.10.4. Italy
    • 12.10.5. Spain
    • 12.10.6. Rest of Europe
  • 12.11. Market Attractiveness Analysis
    • 12.11.1. By Technology
    • 12.11.2. By Formulation Type
    • 12.11.3. By Disease Type
    • 12.11.4. By End-user
    • 12.11.5. By Country/Sub-region

13. Asia Pacific Ocular Drug Delivery Technology Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Technology, 2020-2034
    • 13.2.1. Topical
    • 13.2.2. Ocular Insert
      • 13.2.2.1. Erodible
      • 13.2.2.2. Non-erodible
    • 13.2.3. Iontophoresis
    • 13.2.4. Intraocular Implant
      • 13.2.4.1. Biodegradable
      • 13.2.4.2. Non-biodegradable
    • 13.2.5. In Situ Gel & Punctal Plug
    • 13.2.6. Others
  • 13.3. Market Attractiveness, by Technology
  • 13.4. Market Value Forecast, by Formulation Type, 2020-2034
    • 13.4.1. Solution
    • 13.4.2. Suspension
    • 13.4.3. Emulsion
    • 13.4.4. Liposome & Nanoparticle
    • 13.4.5. Ointment
  • 13.5. Market Attractiveness, by Formulation Type
  • 13.6. Market Value Forecast, by Disease Type, 2020-2034
    • 13.6.1. Glaucoma
    • 13.6.2. Macular Degeneration
    • 13.6.3. Diabetic Retinopathy
    • 13.6.4. Cataract
    • 13.6.5. Diabetic Macular Edema
    • 13.6.6. Dry Eye Syndrome
    • 13.6.7. Others
  • 13.7. Market Attractiveness, by Disease Type
  • 13.8. Market Value Forecast, by End-user, 2020-2034
    • 13.8.1. Hospitals
    • 13.8.2. Ambulatory Surgical Centers
    • 13.8.3. Ophthalmic Clinics
    • 13.8.4. Homecare Settings
  • 13.9. Market Attractiveness, by End-user
  • 13.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 13.10.1. China
    • 13.10.2. Japan
    • 13.10.3. India
    • 13.10.4. Australia & New Zealand
    • 13.10.5. Rest of Asia Pacific
  • 13.11. Market Attractiveness Analysis
    • 13.11.1. By Technology
    • 13.11.2. By Formulation Type
    • 13.11.3. By Disease Type
    • 13.11.4. By End-user
    • 13.11.5. By Country/Sub-region

14. Latin America Ocular Drug Delivery Technology Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Technology, 2020-2034
    • 14.2.1. Topical
    • 14.2.2. Ocular Insert
      • 14.2.2.1. Erodible
      • 14.2.2.2. Non-erodible
    • 14.2.3. Iontophoresis
    • 14.2.4. Intraocular Implant
      • 14.2.4.1. Biodegradable
      • 14.2.4.2. Non-biodegradable
    • 14.2.5. In Situ Gel & Punctal Plug
    • 14.2.6. Others
  • 14.3. Market Attractiveness, by Technology
  • 14.4. Market Value Forecast, by Formulation Type, 2020-2034
    • 14.4.1. Solution
    • 14.4.2. Suspension
    • 14.4.3. Emulsion
    • 14.4.4. Liposome & Nanoparticle
    • 14.4.5. Ointment
  • 14.5. Market Attractiveness, by Formulation Type
  • 14.6. Market Value Forecast, by Disease Type, 2020-2034
    • 14.6.1. Glaucoma
    • 14.6.2. Macular Degeneration
    • 14.6.3. Diabetic Retinopathy
    • 14.6.4. Cataract
    • 14.6.5. Diabetic Macular Edema
    • 14.6.6. Dry Eye Syndrome
    • 14.6.7. Others
  • 14.7. Market Attractiveness, by Disease Type
  • 14.8. Market Value Forecast, by End-user, 2020-2034
    • 14.8.1. Hospitals
    • 14.8.2. Ambulatory Surgical Centers
    • 14.8.3. Ophthalmic Clinics
    • 14.8.4. Homecare Settings
  • 14.9. Market Attractiveness, by End-user
  • 14.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 14.10.1. Brazil
    • 14.10.2. Mexico
    • 14.10.3. Rest of Latin America
  • 14.11. Market Attractiveness Analysis
    • 14.11.1. By Technology
    • 14.11.2. By Formulation Type
    • 14.11.3. By Disease Type
    • 14.11.4. By End-user
    • 14.11.5. By Country/Sub-region

15. Middle East & Africa Ocular Drug Delivery Technology Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Technology, 2020-2034
    • 15.2.1. Topical
    • 15.2.2. Ocular Insert
      • 15.2.2.1. Erodible
      • 15.2.2.2. Non-erodible
    • 15.2.3. Iontophoresis
    • 15.2.4. Intraocular Implant
      • 15.2.4.1. Biodegradable
      • 15.2.4.2. Non-biodegradable
    • 15.2.5. In Situ Gel & Punctal Plug
    • 15.2.6. Others
  • 15.3. Market Attractiveness, by Technology
  • 15.4. Market Value Forecast, by Formulation Type, 2020-2034
    • 15.4.1. Solution
    • 15.4.2. Suspension
    • 15.4.3. Emulsion
    • 15.4.4. Liposome & Nanoparticle
    • 15.4.5. Ointment
  • 15.5. Market Attractiveness, by Formulation Type
  • 15.6. Market Value Forecast, by Disease Type, 2020-2034
    • 15.6.1. Glaucoma
    • 15.6.2. Macular Degeneration
    • 15.6.3. Diabetic Retinopathy
    • 15.6.4. Cataract
    • 15.6.5. Diabetic Macular Edema
    • 15.6.6. Dry Eye Syndrome
    • 15.6.7. Others
  • 15.7. Market Attractiveness, by Disease Type
  • 15.8. Market Value Forecast, by End-user, 2020-2034
    • 15.8.1. Hospitals
    • 15.8.2. Ambulatory Surgical Centers
    • 15.8.3. Ophthalmic Clinics
    • 15.8.4. Homecare Settings
  • 15.9. Market Attractiveness, by End-user
  • 15.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 15.10.1. GCC Countries
    • 15.10.2. South Africa
    • 15.10.3. Rest of Middle East & Africa
  • 15.11. Market Attractiveness Analysis
    • 15.11.1. By Technology
    • 15.11.2. By Formulation Type
    • 15.11.3. By Disease Type
    • 15.11.4. By End-user
    • 15.11.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 16.2. Market Share Analysis, by Company (2023)
  • 16.3. Company Profiles
    • 16.3.1. Ocular Therapeutix, Inc.
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Alimera Sciences Inc.
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. Allergan (an AbbVie company)
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Bausch Health Companies Inc.
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. EyeGate Pharmaceuticals, Inc.
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Envisia Therapeutics Inc.
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. Clearside Biomedical, Inc.
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Graybug Vision, Inc.
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. Santen Pharmaceutical Co., Ltd.
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. Taiwan Liposome Company, Ltd.
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Product Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview

List of Tables

  • Table 01: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Technology, 2020-2034
  • Table 02: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Formulation Type, 2020-2034
  • Table 03: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 04: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Disease Type, 2020-2034
  • Table 05: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Region, 2020-2034
  • Table 06: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Country, 2020-2034
  • Table 07: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Technology, 2020-2034
  • Table 08: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Formulation Type, 2020-2034
  • Table 09: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Disease Type, 2020-2034
  • Table 10: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 11: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 12: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Technology, 2020-2034
  • Table 13: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Formulation Type, 2020-2034
  • Table 14: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Disease Type, 2020-2034
  • Table 15: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 16: Asia Pacific Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 17: Asia Pacific Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Technology, 2020-2034
  • Table 18: Asia Pacific Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Formulation Type, 2020-2034
  • Table 19: Asia Pacific Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Disease Type, 2020-2034
  • Table 20: Asia Pacific Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 21: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 22: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Technology, 2020-2034
  • Table 23: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Formulation Type, 2020-2034
  • Table 24: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Disease Type, 2020-2034
  • Table 25: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 26: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 27: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Technology, 2020-2034
  • Table 28: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Formulation Type, 2020-2034
  • Table 29: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Disease Type, 2020-2034
  • Table 30: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by End-user, 2020-2034

List of Figures

  • Figure 01: Global Ocular Drug Delivery Technology Market Size (US$ Mn), by Region, 2023 and 2034
  • Figure 02: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn), by Technology, 2023
  • Figure 03: Global Ocular Drug Delivery Technology Market Value Share, by Technology, 2023
  • Figure 04: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn), by Formulation Type, 2023
  • Figure 05: Global Ocular Drug Delivery Technology Market Value Share, by Formulation Type, 2023
  • Figure 06: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn), by Disease Type, 2023
  • Figure 07: Global Ocular Drug Delivery Technology Market Value Share, by Disease Type, 2023
  • Figure 08: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn), by End-user, 2023
  • Figure 09: Global Ocular Drug Delivery Technology Market Value Share, by End-user, 2023
  • Figure 10: Global Ocular Drug Delivery Technology Market Value Share, by Region, 2023
  • Figure 11: Global Ocular Drug Delivery Technology Market Value (US$ Mn) Forecast, 2020-2034
  • Figure 12: Global Ocular Drug Delivery Technology Market Value Share Analysis, by Technology, 2023 and 2034
  • Figure 13: Global Ocular Drug Delivery Technology Market Attractiveness Analysis, by Technology, 2024-2034
  • Figure 14: Global Ocular Drug Delivery Technology Market Value Share Analysis, by Formulation Type, 2023 and 2034
  • Figure 15: Global Ocular Drug Delivery Technology Market Attractiveness Analysis, by Formulation Type, 2024-2034
  • Figure 16: Global Ocular Drug Delivery Technology Market Value Share Analysis, by Disease Type, 2023 and 2034
  • Figure 17: Global Ocular Drug Delivery Technology Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 18: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn), by End-user, 2023
  • Figure 19: Global Ocular Drug Delivery Technology Market Value Share, by End-user, 2023
  • Figure 20: Global Ocular Drug Delivery Technology Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 21: Global Ocular Drug Delivery Technology Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 22: North America Ocular Drug Delivery Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 23: North America Ocular Drug Delivery Technology Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 24: North America Ocular Drug Delivery Technology Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 25: North America Ocular Drug Delivery Technology Market Value Share Analysis, by Technology, 2023 and 2034
  • Figure 26: North America Ocular Drug Delivery Technology Market Value Share Analysis, by Formulation Type, 2023 and 2034
  • Figure 27: North America Ocular Drug Delivery Technology Market Value Share Analysis, by Disease Type, 2023 and 2034
  • Figure 28: North America Ocular Drug Delivery Technology Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 29: North America Ocular Drug Delivery Technology Market Attractiveness Analysis, by Technology, 2024-2034
  • Figure 30: North America Ocular Drug Delivery Technology Market Attractiveness Analysis, by Formulation Type, 2024-2034
  • Figure 31: North America Ocular Drug Delivery Technology Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 32: North America Ocular Drug Delivery Technology Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 33: Europe Ocular Drug Delivery Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 34: Europe Ocular Drug Delivery Technology Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 35: Europe Ocular Drug Delivery Technology Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 36: Europe Ocular Drug Delivery Technology Market Value Share Analysis, by Technology, 2023 and 2034
  • Figure 37: Europe Ocular Drug Delivery Technology Market Value Share Analysis, by Formulation Type, 2023 and 2034
  • Figure 38: Europe Ocular Drug Delivery Technology Market Value Share Analysis, by Disease Type, 2023 and 2034
  • Figure 39: Europe Ocular Drug Delivery Technology Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 40: Europe Ocular Drug Delivery Technology Market Attractiveness Analysis, by Technology, 2024-2034
  • Figure 41: Europe Ocular Drug Delivery Technology Market Attractiveness Analysis, by Formulation Type, 2024-2034
  • Figure 42: Europe Ocular Drug Delivery Technology Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 43: Europe Ocular Drug Delivery Technology Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 44: Asia Pacific Ocular Drug Delivery Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 45: Asia Pacific Ocular Drug Delivery Technology Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 46: Asia Pacific Ocular Drug Delivery Technology Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 47: Asia Pacific Ocular Drug Delivery Technology Market Value Share Analysis, by Technology, 2023 and 2034
  • Figure 48: Asia Pacific Ocular Drug Delivery Technology Market Value Share Analysis, by Formulation Type, 2023 and 2034
  • Figure 49: Asia Pacific Ocular Drug Delivery Technology Market Value Share Analysis, by Disease Type, 2023 and 2034
  • Figure 50: Asia Pacific Ocular Drug Delivery Technology Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 51: Asia Pacific Ocular Drug Delivery Technology Market Attractiveness Analysis, by Technology, 2024-2034
  • Figure 52: Asia Pacific Ocular Drug Delivery Technology Market Attractiveness Analysis, by Formulation Type, 2024-2034
  • Figure 53: Asia Pacific Ocular Drug Delivery Technology Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 54: Asia Pacific Ocular Drug Delivery Technology Market Attractiveness Analysis, by End-user, 2023-2034
  • Figure 55: Latin America Ocular Drug Delivery Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 56: Latin America Ocular Drug Delivery Technology Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 57: Latin America Ocular Drug Delivery Technology Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 58: Latin America Ocular Drug Delivery Technology Market Value Share Analysis, by Technology, 2023 and 2034
  • Figure 59: Latin America Ocular Drug Delivery Technology Market Value Share Analysis, by Formulation Type, 2023 and 2034
  • Figure 60: Latin America Ocular Drug Delivery Technology Market Value Share Analysis, by Disease Type, 2023 and 2034
  • Figure 61: Latin America Ocular Drug Delivery Technology Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 62: Latin America Ocular Drug Delivery Technology Market Attractiveness Analysis, by Technology, 2024-2034
  • Figure 63: Latin America Ocular Drug Delivery Technology Market Attractiveness Analysis, by Formulation Type, 2024-2034
  • Figure 64: Latin America Ocular Drug Delivery Technology Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 65: Latin America Ocular Drug Delivery Technology Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 66: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 67: Middle East & Africa Ocular Drug Delivery Technology Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 68: Middle East & Africa Ocular Drug Delivery Technology Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 69: Middle East & Africa Ocular Drug Delivery Technology Market Value Share Analysis, by Technology, 2023 and 2034
  • Figure 70: Middle East & Africa Ocular Drug Delivery Technology Market Value Share Analysis, by Formulation Type, 2023 and 2034
  • Figure 71: Middle East & Africa Ocular Drug Delivery Technology Market Value Share Analysis, by Disease Type, 2023 and 2034
  • Figure 72: Middle East & Africa Ocular Drug Delivery Technology Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 73: Middle East & Africa Ocular Drug Delivery Technology Market Attractiveness Analysis, by Technology, 2024-2034
  • Figure 74: Middle East & Africa Ocular Drug Delivery Technology Market Attractiveness Analysis, by Formulation Type, 2024-2034
  • Figure 75: Middle East & Africa Ocular Drug Delivery Technology Market Attractiveness Analysis, by Disease Type, 2024-2034
  • Figure 76: Middle East & Africa Ocular Drug Delivery Technology Market Attractiveness Analysis, by End-user, 2024-2034